US Patent Issued to BEIJING STARMAB BIOMED TECHNOLOGY on Sept. 1 for "Monospecific and multi-specific antibodies" (California Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,105, issued on Sept. 1, was assigned to BEIJING STARMAB BIOMED TECHNOLOGY LTD (Beijing).

"Monospecific and multi-specific antibodies" was invented by Yanbin Liang (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides monospecific and multi-specific single chain antibodies directed against one or more of the human antigens: CD47, PD-L1, HSA, CD33, LAG3, and CD16. Also provided are methods of administering a pharmaceutical composition of a multi-specific antibody with antigen-binding specificity for two different antigens and methods for treating various diseases, including Alzheimer's disease, cancer, and retinal disea...